Index by author

January 01, 2024; Volume 91,Issue 1

  1. Sekizawa, Akinori

    1. Conjunctival petechiae in infective endocarditis
      Akinori Sekizawa, MD, Ayaka Nagano, MD, Kenichi Hashimoto, MD, PhD and Yosuke Ono, MD, PhD
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 20-21; DOI: https://doi.org/10.3949/ccjm.91a.23041

      A 75-year-old-man presented with a 33-day history of intermittent nocturnal fevers of 39°C (102°F) and truncal rashes. The rashes appeared on the same day as the fever.

  2. Shah, Sachin D.

    1. 2023 Update in ambulatory general internal medicine
      Jason T. Alexander, MD, Simran K. Singh, MD, Sachin D. Shah, MD, Brianna Lambert, MD and Jeremy P. Smith, MD
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 40-46; DOI: https://doi.org/10.3949/ccjm.91a.23056

      Topics reviewed include prevention of chronic kidney disease progression, diet for preventing secondary cardiovascular disease, prevention of kidney-stone recurrence, drug therapy for weight loss, and cholesterol management.

  3. Singh, Abhayjit

    1. Nonstatin therapy to reduce low-density lipoprotein cholesterol and improve cardiovascular outcomes
      Abhayjit Singh, MD and Leslie S. Cho, MD
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 53-63; DOI: https://doi.org/10.3949/ccjm.91a.23058

      Several new nonstatin medications have been approved in recent years, with robust data from clinical trials supporting their use in atherosclerotic disease.

  4. Singh, Simran K.

    1. 2023 Update in ambulatory general internal medicine
      Jason T. Alexander, MD, Simran K. Singh, MD, Sachin D. Shah, MD, Brianna Lambert, MD and Jeremy P. Smith, MD
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 40-46; DOI: https://doi.org/10.3949/ccjm.91a.23056

      Topics reviewed include prevention of chronic kidney disease progression, diet for preventing secondary cardiovascular disease, prevention of kidney-stone recurrence, drug therapy for weight loss, and cholesterol management.

  5. Skoza, Warren

    1. When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
      Osamah Z. Badwan, MD, Lorenzo Braghieri, MD, Warren Skoza, MD, Ankit Agrawal, MD, Venu Menon, MD and W. H. Wilson Tang, MD
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 47-51; DOI: https://doi.org/10.3949/ccjm.91a.23034

      Evidence from clinical trials supports starting these medications as early as possible in patients hospitalized with acute decompensated heart failure who do not have clear contraindications to them.

  6. Smith, Jeremy P.

    1. 2023 Update in ambulatory general internal medicine
      Jason T. Alexander, MD, Simran K. Singh, MD, Sachin D. Shah, MD, Brianna Lambert, MD and Jeremy P. Smith, MD
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 40-46; DOI: https://doi.org/10.3949/ccjm.91a.23056

      Topics reviewed include prevention of chronic kidney disease progression, diet for preventing secondary cardiovascular disease, prevention of kidney-stone recurrence, drug therapy for weight loss, and cholesterol management.

  7. Sroubek, Jakub

    1. Wearable cardiac monitors: Where do we stand?
      Jakub Sroubek, MD, PhD
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 31-32; DOI: https://doi.org/10.3949/ccjm.91a.23081

      Wearable monitors perform well as screening tools for atrial fibrillation, but questions remain: Can they help with stroke prevention, what is their role in patients with known atrial fibrillation, and how do we streamline interpretation?

Back to top

In this issue